Jasper Therapeutics, Inc. · NASDAQ:JSPR
Velan Capital Investment Management LP reported a 9.88% stake in Jasper Therapeutics, Inc. (Schedule 13D/A)
Event Jul 16, 2026 · Filed Jul 20, 2026
Velan Capital Investment Management LP reported a 9.88% stake in Jasper Therapeutics, Inc., 3,349,547 shares, with active intent on Jul 16, 2026. Filed Jul 20, 2026 (Schedule 13D/A).
- Stake
- 9.88%
- Shares
- 3,349,547
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 12 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Velan Capital Master Fund LP | 8.90% | 3,021,915 |
| Velan Capital Holdings LLC | 8.90% | 3,021,915 |
| Velan Horizon Fund LP | 0.20% | 82,304 |
| Velan Horizon GP LLC | 0.20% | 82,304 |
| Avego Healthcare Capital, L.P. | 0.70% | 245,328 |
| Avego Healthcare Capital Holdings, LLC | 0.70% | 245,328 |
| Avego Management LLC | 0.70% | 245,328 |
| Velan Capital Investment Management LP | 9.88% | 3,349,547 |
| Velan Capital Management LLC | 9.88% | 3,349,547 |
| Morgan Adam | 9.88% | 3,349,547 |
| VENKATARAMAN BALAJI | 9.88% | 3,349,547 |
| Kapoor Vishal | 0.10% | 35,013 |
Source
Related
- Jasper Therapeutics, Inc.
- Velan Capital Investment Management LP
- Jasper Therapeutics, Inc. shareholders
- Schedule 13G · Velan Capital Investment Management LP · Aug 17, 2026
- Schedule 13D/A · Velan Capital Investment Management LP · Sep 23, 2025
- Schedule 13G/A · Millennium Management LLC · Jul 10, 2026
- Schedule 13G/A · Morgan Stanley · May 12, 2026
- Schedule 13G/A · Goldman Sachs Group Inc · May 8, 2026
- Schedule 13G/A · Soleus Capital Master Fund, L.P. · May 8, 2026
- Schedule 13G · Millennium Management LLC · Feb 25, 2026